Percutaneous Nephrolithotomy (PCNL)
11
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Anterior QLB for PCNL
A Multifunctional Miniature Nephroscope for Percutaneous Nephrolithotomy
Erector Spinae Plane Block for Percutaneous Nephrolithotomy
Comparative Study Between One-Shot Dilatation Versus Serial Dilatation Techniques for Access in Percutaneous Nephrolithotomy in Adult Patients
Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy
Surgical Position and Hemodynamics in PCNL
Intrathecal Fentanyl and Dexmedetomidine Added to Bupivacaine for Subarachnoid Anaesthesia for Percutaneous Nephrolithotomy
Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL
Retrolaminar Block Improves Postoperative Gastrointestinal System Functions:
The Effect of NSAID Steroid Therapy for PGE2 Level and Analgesia After Percutaneous Nephrolithotomy Surgery
Prone Versus Prone-Flexed Position For Percutaneous Nephrolithotomy (PCNL)